Mrs. Lukito wanted to break the “hereditary” cancer chain. Her mother died from cancer, her aunt also had cancer, and she herself was eventually diagnosed with it. At that time, her breast was already severely affected. However, she did not want to experience the same fate as her mother and other family members. Therefore, she continued to seek alternative treatments, which eventually led her to ECCT 9 years ago.
RIGHT: Image and ultrasound results of Mrs. Lukito from early 2016 showing a malignant mass around the left breast areola; SECOND FROM RIGHT: Ultrasound image 1 to 1.5 years after using the device, showing no visible malignant mass; SECOND FROM LEFT: Image showing the breast’s electrical activity before (03/08/2016), 2 months, and 4 months after using ECCT, with normal activity visible after 4 months; LEFT: Photo of Mrs. Lukito 9 years after first using the device, or 10 years since being diagnosed with breast cancer.
Mrs. Lukito has a family history of cancer. Her mother was the first to be diagnosed with cancer and passed away after undergoing conventional treatments. Then, her aunt was also diagnosed and was undergoing treatment at the hospital. In 2015, her worst fear came true, and she too was diagnosed with breast cancer. She believed cancer was hereditary, but she did not want to resign to the “fate” caused by heredity. She did not want to follow the same path as her mother and other family members. Therefore, Mrs. Lukito continued searching for alternative ways to break free from the “grip” of hereditary cancer that leads to death.
In general, heredity can indeed influence the risk of certain cancers, although personal preferences or choices (such as diet, lifestyle, etc.) also play a significant role. There are several ways heredity may relate to cancer risk:
- Genetics: Some types of cancer are influenced by genetic factors, such as breast cancer, ovarian cancer, colorectal cancer, and others. In some cases, genetic mutations inherited from parents can increase the risk of cancer. For instance, mutations in the BRCA1 and BRCA2 genes increase the risk of breast and ovarian cancer.
- Family History: If close family members have cancer, a person’s risk of developing that cancer may be higher. While genetic factors play a role, this may also be influenced by similar lifestyle habits in the family (such as diet, smoking habits, or environmental exposure).
- Inherited Diseases: Some rare genetic syndromes, like Lynch syndrome (which increases the risk of colorectal cancer), can be passed down in families and cause a predisposition to certain cancers.
However, it is important to note that although heredity can affect cancer risk, many other factors such as the environment, lifestyle (such as diet, exercise, smoking, or exposure to harmful substances), and random factors also contribute significantly to cancer development.
Overall, while heredity may predispose someone to cancer, a healthy lifestyle, early detection, and genetic testing (for those at high risk) can help reduce the risk.
Mrs. Lukito did not want to experience the same fate as her mother and family members. Therefore, she continued searching for alternative treatments, which eventually led her to ECCT 9 years ago. In the early stages of using the device, a liquid mixed with mucus and an unpleasant odor kept coming out from the wound. After one month, the mucus stopped, the liquid became clear, and the wound started to clean up and gradually closed. The wound on her breast fully healed within 2 months.
With ECCT, highly malignant cells undergo death similar to “melting,” turning into mucus. If the mucus can drain properly, the lump can shrink relatively quickly (1-3 months). The presence of the wound aids the faster removal process (following the fluid mechanics principle). Therefore, in Mrs. Lukito’s case, the lump disappeared in one month, and the wound healed in two months. For low malignancy cases, cancer cells are often rich in lipid compounds (cholesterol fats), making them difficult to remove, even with the presence of a wound, thus sometimes requiring surgery assistance.
A year later, Mrs. Lukito’s ultrasound showed no detectable lumps, and her breast was completely normal. That same year, she became pregnant and gave birth and breastfed naturally. She stopped using the device during pregnancy and while breastfeeding, but using it didn’t affect the pregnancy or breastfeeding process. Cancer did not prevent her from having a normal pregnancy and children.
After finishing breastfeeding, Mrs. Lukito resumed using the device for preventive purposes, and it’s now been almost 9 years. Her condition is normal, and she is free from cancer, successfully breaking the cancer chain in her family.
We wish Mrs. Lukito continued good health (WS).
